(Q44331222)

English

Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution

scientific article published on 11 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

Maciej Machaczka

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

8

object named as

P Ljungman

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

H Nahi

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M Remberger

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

J Ungerstedt

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

J Mattson

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

O Ringden

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Katarina Le-Blanc

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

H Hägglund

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

11 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2348-2358

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

https://scigraph.springernature.com/pub.10.1007/s12032-011-0155-y

0 references

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Implications of NRAS mutations in AML: a study of 2502 patients

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Parameters for predicting allogeneic PBSCT outcome of acute myeloid leukemia: cytogenetics at presentation versus disease status at transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Risk assessment in patients with acute myeloid leukemia and a normal karyotype

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Cytogenetics in acute leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

New insights to the MLL recombinome of acute leukemias

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0155-Y

21 January 2018

Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marro

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Internal tandem duplication of the flt3 gene found in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to chemotherapy in acute leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Infection-Related Mortality in KIR-Ligand???Mismatched Unrelated Allogeneic Hematopoietic Stem-Cell Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An International System for Human Cytogenetic Nomenclature (1985) ISCN 1985. Report of the Standing Committee on Human Cytogenetic Nomenclature

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the role of reduced-intensity transplantation in the treatment of older patients with AML?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22234457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-011-0155-Y

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

release_jf4t4zekkzdpvju5wssxjxv2o4

1 reference

https://api.fatcat.wiki/v0/release/jf4t4zekkzdpvju5wssxjxv2o4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44331222&oldid=2109490461"